34 results
PRER14A
GLSHQ
Gelesis Holdings, Inc.
7 Sep 23
Preliminary revised proxy
4:03pm
other things, Torreya’s qualifications, experience, reputation and its knowledge of and involvement in recent transactions in the life sciences
PREM14A
GLSHQ
Gelesis Holdings, Inc.
24 Jul 23
Preliminary proxy related to merger
9:47pm
of strategic alternatives based on, among other things, Torreya’s qualifications, experience, reputation and its knowledge of and involvement in recent
424B3
GLSHQ
Gelesis Holdings, Inc.
16 Nov 22
Prospectus supplement
4:51pm
impact the commercial growth and success of Plenity and, consequently, could cause our revenue, earnings or reputation to suffer … reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of Plenity and could substantially
424B3
GLSHQ
Gelesis Holdings, Inc.
16 Nov 22
Prospectus supplement
4:48pm
impact the commercial growth and success of Plenity and, consequently, could cause our revenue, earnings or reputation to suffer … reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of Plenity and could substantially
424B3
e7ms1i5jo1fmln96
16 Sep 22
Prospectus supplement
11:19am
424B3
wzeh9o h8q
6 Sep 22
Prospectus supplement
4:53pm
424B3
ux07nwh
8 Jun 22
Prospectus supplement
4:21pm
8-K
EX-14.1
bpqqkei
20 Jan 22
Proceeds from this transaction will be used to further support the national launch of Plenity
5:24pm
424B3
bifri
27 Dec 21
Prospectus supplement
12:00am